2008Journal of Bethune Military Medical CollegeRequires access

Observation on the Effect of Lamivudine on 36 Patients with Chronic Hepatitis B

YU Zhangu

Open publisher page 0 citations

Abstract

Objective To observe the clinical efficacy of for the treatment of chronic hepatitis B.Methods 72 cases were randomly divided into the observation group(n=36) and control group(n=36).Control group were treated by INF-a with a course of 3 months.observation group were treated by lamivudine with a course of 12 months.Results The markedly effective rate of treatment group was significantly higher than that of control group(44.4% vs 13.9%,P0.01).The total effective rate of treatment group was significantly higher than that of control group(61.1% vs 33.3%,P0.05) too.There were no significant differences in the rates for HBeAg and HBV-DNA to change to negative between the two groups(P0.05).Conclusion Lamivudine is effective and safe in treatment of cases with chronic hepatitis B.

About this research paper

What this paper is about

Objective To observe the clinical efficacy of for the treatment of chronic hepatitis B.Methods 72 cases were randomly divided into the observation group(n=36) and control group(n=36).Control group were treated by INF-a with a course of 3 months.observation group were treated by lamivudine with a course of 12 months.Results The markedly effective rate of treatment group was significantly higher than that of control group(44.4% vs 13.9%,P0.01).The total effective rate of treatment group was significantly higher than that of control group(61.1% vs 33.3%,P0.05) too.There were no significant differences in the rates for HBeAg and HBV-DNA to change to negative between the two groups(P0.05).Conclusion Lamivudine is effective and safe in treatment of cases with chronic hepatitis B.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical efficacy of for the treatment of chronic hepatitis B.Methods 72 cases were randomly divided into the observation group(n=36) and control group(n=36).Control group were treated by INF-a with a course of 3 months.observation group were treated by lamivudine with a course of 12 months.Results The markedly effective rate of treatment group was significantly higher than that of control group(44.4% vs 13.9%,P0.01).The total effective rate of treatment group was significantly higher than that of control group(61.1% vs 33.3%,P0.05) too.There were no significant differences in the rates for HBeAg and HBV-DNA to change to negative between the two groups(P0.05).Conclusion Lamivudine is effective and safe in treatment of cases with chronic hepatitis B.

Key concepts: Lamivudine, Medicine, Chronic hepatitis, Internal medicine, Gastroenterology, HBeAg, Hepatitis B, Treatment and control groups

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation on the Effect of Lamivudine on 36 Patients with Chronic Hepatitis B — Research Paper | ScholarLens